FDA Approved: MITIGARE — Supplemental Application (Hikma Specialty USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Mitigare (colchicine) submitted by Hikma Specialty USA Inc. The action updates the product label/indication through …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Mediterranean Fever
• Gout
• Pericarditis

Drugs mentioned

• MITIGARE (Colchicine)

Snippet

SUPPL AP for MITIGARE (COLCHICINE)